MDI Biological Laboratory

Archive for: Peripheral neuropathy

Bringing Nerve Regeneration from Tank to Bedside: An Interview With Sandra Rieger, Ph.D.

Sandra Rieger, Ph.D, assistant professor at the MDI Biological Laboratory, discusses how her laboratory is utilizing zebrafish as a model to study wound healing mechanisms and nerve regeneration in patients with peripheral neuropathy in an interview that originally appeared in the online publication, Regenerative Medicine Network.

Continue Reading

The Patient Perspective: How Patient Interaction Helps Laboratory Research

The importance of interaction between patients and researchers is the subject this discussion by MDI Biological Laboratory assistant professor, Sandra Rieger, Ph.D., who is studying chemotherapy-induced peripheral neuropathy using the zebrafish as a research model.

Continue Reading

Cool Videos: Regenerating Nerve Fibers

If you enjoy action movies, you can probably think of a superhero—maybe Wolverine?—who can lose a limb in battle, yet grow it right back and keep on going. But could regenerating a lost limb ever happen in real life? In this guest post, Dr. Francis Collins, director of the National Institutes of Health, discusses the how scientists including Sandra Rieger, Ph.D., of the MDI Biological Laboratory are striving to understand how other organisms do this.

Continue Reading

Laboratory Receives Funds for Research on Peripheral Neuropathy

The MDI Biological Laboratory has received a grant of $456,500 over two years from the National Institute of Neurological Disorders and Stroke for the study of peripheral neuropathy. The grant will support research conducted by assistant professor Sandra Rieger, Ph.D., on chemotherapy-induced peripheral neuropathy, a disabling condition causing pain, numbness, tingling and temperature sensitivity in…

Continue Reading

MDI Biological Laboratory Announces Potential New Therapy for Nerve Damage

Assistant Professor Sandra Rieger, Ph.D., has identified two drugs that could potentially be used to reverse peripheral nerve damage, or peripheral neuropathy, resulting from cancer chemotherapy treatment. The drugs also have potential applications for the treatment of peripheral neuropathies caused by other conditions. The drugs are the subject of a provisional patent filed by the…

Continue Reading